FL-EIGHT-SLEEP
27.7.2022 17:02:04 CEST | Business Wire | Press release
Today, Eight Sleep , the world’s first sleep fitness company, introduced Pod 3, a new version of their award-winning sleep technology. Pod 3 features a new quad-core CPU as well as upgrades to its sensor system, powering more accurate biometric and health tracking with twice the number of sensors and 4000x greater resolution. The new sensor system achieves 99% heart rate sensing accuracy compared to clinical reference¹. Furthermore, clinical data have shown that the technology behind Pod 3 can improve sleep quality index by up to 32%², increase deep sleep by up to 34%³, and increase heart rate variability (HRV) by up to 19%³. The release of Pod 3 is part of Eight Sleep’s journey to transform an ordinary bed into an advanced health platform that fuels both recovery and performance.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727005241/en/
“From the start, we set out to create the best systems in the world to power sleep optimization, and with the launch of Pod 3 we are taking a giant leap forward,” said Matteo Franceschetti, Co-founder and CEO of Eight Sleep . “Three years after the launch of the original Pod, it is rewarding to see how our innovations are improving people’s lives, with clinically validated results that prove better recovery night after night.”
Thermoregulating technology that improves sleep quality and increases HRV
The Pod’s Active Grid layer, which wraps around any mattress like a cover, continues to provide dynamic heating and cooling between 55℉ and 110℉ on each side of the bed. This allows members to maintain a comfortable temperature range during sleep, which has been clinically demonstrated to improve sleep quality index, time spent in deep sleep, as well as heart rate variability:
- Increase deep sleep by up to 34%³: After just one week of sleeping on the Pod, individuals experienced a 10% average increase and a 34% maximum increase in deep sleep. Individuals that initially had below-average deep sleep duration had the largest increase in deep sleep after using the Pod. As deep sleep is crucial for several key bodily processes, including learning and memory, recovery from exercise, immunity, and metabolism, sleeping on the Pod can be highly beneficial for people struggling to get optimal amounts of deep sleep each night.
- Improve clinical sleep quality by up to 32%²: The Pod has been shown to improve the sleep quality of individuals by up to 32% using standard clinical measurements. The average Pod user also experiences 34% higher daytime energy scores, 23% fewer sleep interruptions, and 44% faster sleep onset, compared to their baseline before sleeping on the Pod.
- Increase heart rate variability (HRV) by up to 19%³: After one week of sleeping on the Pod, users show an average increase in their HRV by 6%. For one in three Eight Sleep users, HRV increases by at least 10%, and one in four users sees an HRV increase of at least 15%. Importantly, individuals with a below-average HRV experienced the largest increases in HRV after sleeping on the Pod with an average 9% increase and a 19% maximum increase. An increase in HRV indicates improved recovery, cardiovascular health, and cognitive performance.
While still maintaining the award-winning features of the Pod 2 Pro, the new Pod 3 includes enhanced technology and an improved user experience with the following enhancements:
A new quad-core CPU to increase the Pod’s computing power
A powerful new quad-core CPU significantly increases computing power in Pod 3 that allows for double the amount of sensors for tracking key biometrics such as heart rate, HRV, respiratory rate, sleep stages, and more. With a more robust hardware system, the Pod can now locally process more complex data and algorithms, critical for biometrics tracking during sleep. Additionally, the new hardware allows for future deep-learning-powered features to be pushed to users via frequent cloud updates.
Invisible Sensing design featuring twice the number of sensors and 4000x greater resolution in sleep and health tracking
Pod 3 includes a new Invisible Sensing design of its sensor pack to maximize comfort while providing more accurate measurements with double the amount of sensors and 4000x greater sensor resolution. Building on the previous generation’s excellent biometric accuracy³, Pod 3’s dual sensors enable a further 20% improvement in heart rate variability accuracy, as well as a maximum error of heart rate of less than 1 beat per minute compared to clinical reference.
Dual-band Wi-Fi chip with 5GHz compatibility for a wider connectivity range
A new, dual-band Wi-Fi chip in the Hub extends compatibility from 2.4GHz networks to 5GHz networks, as well as improves support for mesh networks. This update increases connection speed and Wi-Fi stability, allowing the Pod to find the best balance between long-range and high bandwidth connectivity, regardless of the layout of the user’s home.
The Eight Sleep app provides health insights and more with 8+
The powerful features of Pod 3 are managed from the Eight Sleep app which serves as a one-stop dashboard to view health and sleep metrics, adjust sleep preferences, and manage temperature settings. With an optional 8+ membership users can take their sleep to the next level. 8+ unlocks the full intelligence of the product, built utilizing insights from more than 90 million hours of sleep data. The features in the Eight Sleep App include:
- Temperature Autopilot: Autopilot uses AI to adjust the user’s sleeping temperature in real-time based on their sleep history, past temperature preferences, bedroom temperature, local weather, and user feedback.
- Health and Sleep Reports: A Sleep Fitness Report is available daily, and includes key health metrics such as heart rate, heart rate variability, sleep time, deep sleep, REM sleep, and respiratory rate.
- Connection to third-party wearables: Users can link their favorite third-party fitness devices with the Eight Sleep app to understand how their daytime activities affect their sleep. Devices supported include Peloton, Oura, Garmin, Apple Health, Google Health, Fitbit, Trainingpeaks, Polar, and Zwift.
- Behavioral Insights: 8+ offers powerful sleep and health insights, based on more than 90 million hours of sleep data, and creates personalized recommendations for each user with actionable suggestions to promote positive behavior change.
- Content designed to help you sleep: 8+ members get access to a growing library of content including guided breathing, yoga, meditations, and more designed to help users fall asleep faster and wake up energized.
“Pod 3 is the next step for Eight Sleep to push the boundaries of what is possible for sleep technology that not only monitors your health, but also improves it. The new sensing and computing hardware in Pod 3 allows for more complex biometric algorithms to be deployed, giving our members the best and most innovative features for restorative and preventative health. This was all achieved while making the Pod even more comfortable with a new Invisible Sensing design,” says Dr. David He, Vice President of Research and Development at Eight Sleep .
Available today
The Eight Sleep Pod 3 is available to purchase online today. Pricing starts at $2,095 for a Full size, $2,195 for Queen, $2,395 for King and California King Pod 3 Cover. Priority upgrades are available for existing Eight Sleep members. Eight Sleep upholds its customer satisfaction, offering up to a 100-night trial and free returns. For more information about Pod 3, check out the video here and to purchase the Pod, visit eightsleep.com .
About Eight Sleep
Eight Sleep is the world's first sleep fitness company with a mission to fuel human potential through optimal sleep. Their hardware, software, and AI technologies power pro athletes and everyday high performers around the globe, including snowboarding sensation and Olympic Gold-Medalist Red Gerard, the world’s fittest man 2021 CrossFit Games Winner Justin Medeiros, and the 8X Formula One Champions, Mercedes-AMG PETRONAS Formula One Team. Eight Sleep was named one of Fast Company's Most Innovative Companies in 2019 & 2022. The company was also recognized two years in a row by TIME's “Best Inventions of the Year.” Eight Sleep is available for purchase in North America (the United States and Canada) and throughout the United Kingdom, Europe (Belgium, France, Germany, Italy, Netherlands, and Spain) and Australia via eightsleep.com.
References
- Eight Sleep Pod’s Heart Rate and Heart Rate Variability Accuracy
- Eight Sleep Pod Leads to Improved Sleep Quality
- HRV, HR & Deep Sleep Improvement
View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005241/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corient Accelerates European Growth With the Addition of Letus Private Office30.6.2026 07:15:00 CEST | Press release
Leading French multi-family office with approximately US$5 billion in assets is Corient’s fourth European acquisition, growing firm’s global assets to approximately US$523 billion Corient today announced an agreement to acquire Letus Private Office (“Letus”), an independent multi-family office and wealth advisory firm serving entrepreneurs, founders and other ultra-high-net-worth individuals and families across France and Europe. The acquisition, subject to closing, builds on recent transactions that have made Corient the world’s largest multi-family office and non-bank wealth manager focused on ultra-high-net worth and high-net-worth clients. Paris-based Letus was founded in 2016 and is led by Managing Partners Anice Chlagou, Stephen Lasry and Alexandre Tsouli, and Partner Sacha Levy. It manages and administers approximately €4.1 billion (about US$5 billion). Letus serves ultra-high-net worth clients, primarily entrepreneurs and their families, providing comprehensive, bespoke service
“BOCCHI THE ROCK!” SeisyunComplex Premiered on June 20!30.6.2026 07:00:00 CEST | Press release
A New Work for “TOKYO Night & Light” — Surpassing 1.4 Million Total Visitors The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625185578/en/ We are pleased to announce that the first screening of “BOCCHI THE ROCK!” SeisyunComplex, a new projection mapping work inspired by the highly popular anime “BOCCHI THE ROCK!”, was held on Saturday, June 20. Following its premiere, the work will be screened throughout the year as part of the weekday and weekend lineup of “TOKYO Night & Light”. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.4 million. As on
Hengrui’s Heng Yi® Approved in China as an Innovative Cyclosporine Ophthalmic Solution for the Treatment of Dry Eye Disease30.6.2026 07:00:00 CEST | Press release
Hengrui Pharma, a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH (“Novaliq”), a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique EyeSol® water-free platform technology, announce today that on June 23, 2026, the China National Medical Products Administration (NMPA) has approved Heng Yi® (0.1% cyclosporine ophthalmic solution) for the treatment of patients with dry eye disease, aiming to increase tear secretion in patients with reduced tear production and improve the sign of the disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629052295/en/ Heng Yi Heng Yi® is the first and only water-free 0.1% cyclosporine ophthalmic solution and the second dry eye disease drug product approved in China based on the EyeSol® platform technology, following the approval of Heng Qin® (perfluorohexyloctane ophthalmic solution) in 202
Nebex Raises $30M Seed Round Led by GV to Build Market Infrastructure for the Global Space Economy29.6.2026 17:38:00 CEST | Press release
The new funding and banking relationship allow Nebex to scale the market and unlock the commercial space economy. Nebex, the market infrastructure platform for the global space economy, announced a $30M seed investment led by GV (Google Ventures), with participation from other top-tier venture funds. The company also announced a banking relationship with J.P. Morgan. The capital raise and new banking relationship will help Nebex scale its platform and connect sovereign space programs with the founders and companies building new technologies to serve the space industry. "We built Nebex because we've seen firsthand that ambitious space founders struggle to deliver complex sovereign programs due to the lack of capital markets infrastructure that supports revenue and cashflow. This is something that exists in nearly every other industry," said Tejpaul Bhatia, CEO of Nebex. "Support from these organizations gives Nebex the additional leverage and financial infrastructure to build the global
Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos29.6.2026 16:19:00 CEST | Press release
Medisca today announced that Founder and Chairman Antonio Dos Santos has returned to the role of Chief Executive Officer as the company enters its next chapter of growth. For more than 35 years, Dos Santos has helped shape Medisca into a global leader in pharmaceutical compounding. As Chief Executive Officer, he will lead the company's long-term strategy, with a focus on expanding Medisca's global reach, investing in new areas of growth, strengthening strategic partnerships, and continuing to advance the products, services, education, and expertise that healthcare professionals rely on every day. "When I founded Medisca, my vision was to raise the standard of pharmaceutical compounding by bringing pharmaceutical-grade quality to the industry and giving healthcare professionals access to the products, knowledge, and innovation they needed to deliver better patient care," said Antonio Dos Santos, Founder and Chief Executive Officer of Medisca. "That purpose continues to guide us. As we b
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
